Man Group’s Day One Biopharmaceuticals DAWN Stock Holding History

Man Group’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-200,000	Closed	-$4.29M	–	2396
2026 Q1	$4.29M	Buy	200,000 +2,904	+1%	+$40.9K	0.01%	1229
2025 Q4	$1.84M	Buy	197,096 +105,278	+115%	+$880K	﹤0.01%	1477
2025 Q3	$647K	Buy	91,818 +34,956	+61%	+$241K	﹤0.01%	1790
2025 Q2	$370K	Buy	56,862 +17,950	+46%	+$123K	﹤0.01%	1915
2025 Q1	$309K	Buy	38,912 +26,113	+204%	+$281K	﹤0.01%	1926
2024 Q4	$162K	Buy	+12,799	New	+$178K	﹤0.01%	1898

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Man Group's DAWN Position: Q2 2026 in Review

Man Group sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 200,000 shares — an estimated $4.29M sold.

Man Group first reported a position in DAWN in Q4 2024 and held it in 6 quarters. The position peaked at $4.29M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Man Group reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Man Group sold 200,000 Day One Biopharmaceuticals shares in Q2 2026, an estimated $4.29M.
Man Group first reported a position in Day One Biopharmaceuticals in Q4 2024 and held it in 6 quarters.
Man Group's Day One Biopharmaceuticals position peaked at $4.29M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.